Rare lung cancers—2021 update on challenges, advances, and opportunities Andreas Pircher editorial 06 December 2021 Pages: 317 - 318
ASCO 2021—an update on metastastic colorectal cancer Lukas Weiss short review Open access 26 October 2021 Pages: 319 - 322
ASCO 2021: Highlights in central nervous system tumors Maximilian J. MairAnna S. Berghoff short review Open access 11 October 2021 Pages: 323 - 327
Best of ASCO 2021: new data from triple-negative breast cancer Christian Singer short review Open access 04 October 2021 Pages: 328 - 330
ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma Thorsten Fuereder short review Open access 27 October 2021 Pages: 331 - 334
Best of ASCO 2021—bladder cancer Karl MayrhoferDora Niedersüß-Beke short review 25 October 2021 Pages: 335 - 337
ASCO 2021–Gastroesophageal tumor highlights Aysegül Ilhan-Mutlu short review Open access 08 October 2021 Pages: 338 - 341
Ovarian cancer—ASCO annual meeting update 2021 Johannes SchöcheKathrin Strasser-Weippl short review 21 October 2021 Pages: 342 - 346
ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer Gudrun AbsengerAndreas Pircher review Open access 18 October 2021 Pages: 347 - 349
Practical considerations for the management of immune thrombocytopenic purpura Michael FillitzBarbara DixerFelix Keil review 18 October 2021 Pages: 350 - 354
Laboratory thrombophilia screening: essentials for hematologists Paul A. Kyrle short review 29 October 2021 Pages: 360 - 363
Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL) Rasha I. IbrahimHaydi S. MohamedAlia M. Saeed original report 18 June 2021 Pages: 364 - 372
The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours Wolfgang Jungraithmayr comment 20 August 2021 Pages: 373 - 375
Unresectable pleural mesothelioma—hope or still an unmet medical need? Gudrun AbsengerAngelika Terbuch short review Open access 17 August 2021 Pages: 376 - 380
Neuroendocrine neoplasms of the lung: a pathology update Jasna MetovicMarco BarellaGiuseppe Pelosi short review Open access 21 May 2021 Pages: 381 - 385
Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib Louisa HempelJakob MolnarDirk Hempel case report 06 July 2021 Pages: 386 - 391
Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report Laurenz NaglAndreas SeeberAndreas Pircher case report Open access 20 August 2021 Pages: 392 - 396
The value of immunotherapy in pediatric leukemia and lymphoma Elisabeth SalzerAndishe Attarbaschi short review Open access 08 November 2021 Pages: 397 - 401
Ponatinib and palbociclib combination in TKI-resistant CML—A case report Johannes B. JaegerThomas JaegerBernd Lorenz Hartmann case report 20 September 2021 Pages: 402 - 405
Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma? Wael Khair review 04 October 2021 Pages: 406 - 411